Vineet Laboratories share news and announcements

NSE: VINEETLABBSE: 543298Pharmaceuticals & BiotechnologySmall Cap

₹36.23₹0.96 (2.58%)BSE ₹35.55

Share price at the NSE close on 23 Oct 2026. Previous close ₹37.19.

52-week range of traded prices to 23 Oct 2026

₹27.96Low, 9 Mar 2026₹49.99High, 30 Oct 2025

Next results date: the board meets on 26 Oct 2026 to consider: financial results and other business matters.

Market cap: ₹70 Cr3,234th largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, NSE: 1,53,94574.5% delivered

Vineet Laboratories board meetings

50 filed, newest first.

Oct 2026
- 21 Oct · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters (opens in a new tab)
Aug 2026
- 20 Aug · Board meeting
  Board Meeting to be held on 25-Aug-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . (opens in a new tab)
Jul 2026
- 11 Jul · Board meeting
  Board Meeting to be held on 15-Jul-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . (opens in a new tab)
May 2026
- 26 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026 (opens in a new tab)
Feb 2026
- 10 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2025 along with the limited review report. (opens in a new tab)
Jan 2026
- 7 Jan · Board meeting
  Outcome Of Board Meeting Held On Wednesday, January 07, 2026 As Required Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 {'SEBI(LODR)'}. (opens in a new tab)
Nov 2025
- 27 Nov · Board meeting
  Board Meeting to be held on 03-Dec-2025 to consider and approve Fund raising/Other business. (opens in a new tab)
- 27 Nov · Board meeting
  Board of Directors of the Company at its meeting held today i.e., on Thursday, November 27, 2025, approved the following:1. Raise of funds by way of issue of equity shares of the Company of face value Rs.10/- (RupeeTen Only) each for an aggregate amount not exceeding Rs.3,000 Lakhs (Rupees ThreeThousand Lakhs) on Right issue basis, on such terms and conditions as may be decided bythe Board of Directors / Rights Issue Committee to the eligible equity shareholders of theCompany, as on the record date (to be notified subsequently).The issue is subject to the receipt of applicable regulatory, statutory approvals, inaccordance with the provisions of the Securities and Exchange Board of India (Issue ofCapital and Disclosure Requirements) Regulations, 2018, Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements), Regulations, 2015, and theCompanies Act, 2013 and the rules made thereunder, as amended from time to time.2. Constitution of the Rights Issue Committee, consisting of Mr. Gaddam Venkata Ramana,Mr. Satyanarayana Raju Bhupathiraju, Mr. Premananda Reddy Vennapusa, Mr. Dilip VishnuAcharekar empowering them to undertake all the necessary activities for the completion ofthe proposed Rights Issue. (opens in a new tab)
- 24 Nov · Board meeting
  To consider and approve the proposal of Fund Raising by way of issue of equity shares through Rights Issue. (opens in a new tab)
- 8 Nov · Board meeting
  Board of Directors of the company in its meeting held today i.e., Saturday, November 08, 2025 has: considered and approved the unaudited standalone financial results of the company for the Second quarter and the half year ended on September 30, 2025 along with the Limited Review Report submitted by the Statutory Auditors. based on the recommendation of Nomination and Remuneration Committee - unanimously approved the appointment of Ms. Jasmin Kunal Tailor (DIN: 10794164) as an Additional Non-Executive Independent Director for a term of 3 (Three) consecutive years with effect from 9th November 2025 to 8th November 2028, subject to the subsequent approval of the shareholders of the company. noted the resignation of Ms. Hari Priya Yerukalapudi (DIN:09690829) from the office of Independent Director w.e.f the close of business hours of 8th November, 2025. based on the recommendation of Nomination and Remuneration Committee - revised the remuneration of Mr. Gaddam Venkata Ramana (DIN: 00031873), Managing Director of the Company, subject to the approval of the shareholders. based on the recommendation of Nomination and Remuneration Committee - revised the remuneration of Mr. Satyanarayana Raju Bhupathiraju (DIN:02697880), Whole Time Director and CFO of the Company, subject to the approval of the shareholders. (opens in a new tab)
- 4 Nov · Board meeting
  To consider and approve the financial results for second quarter & the half year ended on September 30, 2025 along with the limited review report (opens in a new tab)
Oct 2025
- 13 Oct · Board meeting
  To consider and approve the unaudited standalone financial results of the Company for the Second quarter and Half Year ended on September 30, 2025 along with the Limited Review Report. (opens in a new tab)
  Not held on this date
Aug 2025
- 12 Aug · Board meeting
  Outcome of Board Meeting held on August 12, 2025. (opens in a new tab)
Jul 2025
- 15 Jul · Board meeting
  Intimation of the date of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to consider and approve the unaudited standalone financial results of the Company for the first quarter ended on June 30, 2025 along with the Limited Review Report. (opens in a new tab)
May 2025
- 21 May · Board meeting
  Board meeting held on May 21, 2025. (opens in a new tab)
- 14 May · Board meeting
  Outcome of Board Meeting held on May 14, 2025 -The Board of Directors of the company in its meeting held today i.e., on Wednesday, May 14, 2025 has approved the following, subject to the approval of the shareholders:1. the appointment of Mr. Rajesh Kumar Kathulla (DIN: 05349717) as an Additional Director, designated as Whole Time Director of the Company effective May 14, 2025; 2. the increase of Authorised Share Capital from the existing ₨.10,81,00,000/- (Rupees Ten Crore Eighty one Lakh Only) consisting of 1,08,10,000 (One Crore Eight Lakh Ten Thousand Only) equity shares of face value ₨.10.00/- each to ₨ 20,00,00,000/- (Rupees Twenty Crore Only) consisting of 2,00,00,000 (Two Crore Only) equity shares of face value ₨.10.00/- each, and the consequent alteration of Clause V of the Memorandum of Association of the Company. (opens in a new tab)
- 6 May · Board meeting
  To consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended on March 31, 2025. (opens in a new tab)
Feb 2025
- 12 Feb · Board meeting
  Outcome of Board Meeting held on Wednesday, February 12, 2025 as required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 4 Feb · Board meeting
  Board Meeting to be held on February 12, 2025 to inter-alia consider and approve the unaudited standalone financial results of the company for the quarter ended on December 31, 2024 along with limited review report. (opens in a new tab)
Nov 2024
- 13 Nov · Board meeting
  Outcome of Board Meeting held on November 13, 2024. (opens in a new tab)
- 5 Nov · Board meeting
  To consider and approve the unaudited standalone financial results of the Company for the second quarter and half-year ended on 30th September, 2024 along with the Limited Review Report (opens in a new tab)
Aug 2024
- 13 Aug · Board meeting
  Board meeting held on August 13, 2024. (opens in a new tab)
Jul 2024
- 31 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2024 (opens in a new tab)
May 2024
- 29 May · Board meeting
  Sub: Outcome of Board Meeting held on Wednesday, May 29, 2024 as required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015The Board of Directors of the company in its meeting held today i.e., on May 29, 2024 has : Considered and approved Audited Standalone Financial Results of the Company for the 4th quarter and the financial year ended on 31st March, 2024. Taken note of resignation of Mr. Satish Pandurang Samant (DIN:10294920) from the office of Executive Director w.e.f May 29, 2024. Approved the resignation of Mr. Satish Pandurang Samant (DIN:10294920) from the office of Chief Executive Officer w.e.f May 29, 2024 (opens in a new tab)
- 21 May · Board meeting
  To consider and approve the financial results for the 4th quarter and financial year ended on March 31, 2024 (opens in a new tab)
Feb 2024
- 12 Feb · Board meeting
  Board meeting held on February 12, 2024. (opens in a new tab)
- 2 Feb · Board meeting
  Intimation of the date of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
Nov 2023
- 11 Nov · Board meeting
  Revised Outcome of Board Meeting held on Friday, November 10, 2023 as required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 10 Nov · Board meeting
  Board meeting held on November 10, 2023. (opens in a new tab)
- 2 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2023 (opens in a new tab)
Oct 2023
- 16 Oct · Board meeting
  Board meeting held on October 16, 2023.The Board of Directors of the company in its meeting held today i.e., on October 16, 2023 has approved the appointment of Mr. Satish Pandurang Samant (DIN: 10294920) as an Additional Executive Director and Chief Executive Officer (CEO) of the Company effective October 16, 2023. (opens in a new tab)
Aug 2023
- 4 Aug · Board meeting
  To consider & approve the unaudited financial results along with limited review report of the company for the first quarter ended 30th June, 2023 (opens in a new tab)
May 2023
- 18 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2023 (opens in a new tab)
Feb 2023
- 14 Feb · Board meeting
  Board of Directors of the company in its meeting held today i.e., on February 14, 2023 has considered and approved the Unaudited Financial Results of the company for the Third Quarter and Nine months ended on December 31, 2022 along with the Limited Review Report. (opens in a new tab)
- 7 Feb · Board meeting
  This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, February 14, 2023 to consider and approve the Unaudited Financial results of the Company for the 3rd quarter ended on December 31, 2022 along with the Limited Review Report. (opens in a new tab)
Nov 2022
- 14 Nov · Board meeting
  Board Meeting held on 14-Nov-2022 to consider financial statements along with the Limited Review Report for the period ended September 2022 (opens in a new tab)
- 7 Nov · Board meeting
  Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 (opens in a new tab)
Aug 2022
- 30 Aug · Board meeting
  Board of Directors of the company in its meeting held today i.e., on August 30, 2022 has approved the following: 1. Directors Report along with annexures thereto including Corporate Governance Report for the year ended 31st March 2022.2. Notice of the 6th Annual General Meeting to be held in Physical mode on Wednesday, September 28, 2022, at 11:00 a.m. IST. 3. Change in the designation of Mr. Kandula Murali Mohan (DIN: 03313407) from Non-Executive Director to Whole Time Director of the Company and appointing him as such for period of 2 years effective from July 1, 2022 to June 30, 2024, subject to the approval of the members in the ensuing Annual General Meeting. A brief profile is enclosed as Annexure I. 4. Appointment of NSVR & Associates LLP, Chartered Accountants (Firm Registration No.008801S/S200060) as the Statutory Auditors of the Company for a term of 5 (Five) consecutive years i.e. from FY 2022-23 to FY 2026-27, subject to the approval of the members in the ensuing Annual General Meeting. (opens in a new tab)
Jul 2022
- 29 Jul · Board meeting
  Board Meeting held on 29-Jul-2022 , which has considered and approved the unaudited financial results for the quarter ended June 30, 2022 along with Limited Review Report. (opens in a new tab)
- 21 Jul · Board meeting
  Board Meeting to be held on 29-Jul-2022 to consider and approve Financial Results along with the Limited Review Report for the first quarter ended on June 30, 2022. (opens in a new tab)
May 2022
- 28 May · Board meeting
  Board Meeting held on 28-May-2022has recommended dividend @Rs.1 Per Share. (opens in a new tab)
- 28 May · Board meeting
  Board Meeting held on 28-May-2022 to consider financial statements for the period ended March 2022 and Dividend , among other items. (opens in a new tab)
- 20 May · Board meeting
  Board Meeting to be held on 28-May-2022 to consider financial statements for the period ended March 2022 and Other business matters (opens in a new tab)
Feb 2022
- 12 Feb · Board meeting
  Board meeting held on February 12, 2022. (opens in a new tab)
- 4 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2021 (opens in a new tab)
Nov 2021
- 10 Nov · Board meeting
  Board meeting held on November 10, 2021. (opens in a new tab)
- 1 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021 (opens in a new tab)
Aug 2021
- 31 Aug · Board meeting
  Board meeting held on August 31, 2021. (opens in a new tab)
- 2 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021 (opens in a new tab)
Jun 2021
- 16 Jun · Board meeting
  To consider the following: 1. Audited financial results for the quarter and year ended March 31, 2021.2. Any other business with the permission of the Chair. (opens in a new tab)

Vineet Laboratories board meetings

Oct 2026

Aug 2026

Jul 2026

May 2026

Feb 2026

Jan 2026

Nov 2025

Oct 2025

Aug 2025

Jul 2025

May 2025

Feb 2025

Nov 2024

Aug 2024

Jul 2024

May 2024

Feb 2024

Nov 2023

Oct 2023

Aug 2023

May 2023

Feb 2023

Nov 2022

Aug 2022

Jul 2022

May 2022

Feb 2022

Nov 2021

Aug 2021

Jun 2021